RMD
NYSE · Health Care
Resmed Inc
$235.38
+0.08 (+0.03%)
RMD News3 articles
Apnimed Surges 56% in Nasdaq Debut as FDA Decision Looms
Apnimed (NASDAQ:APMD) closes its first day up 56% at $25, valuing the company near $1 billion as the FDA reviews its sleep apnea treatment.
Vivos Therapeutics Stock Jumps 36% on Debt-to-Equity Swap to Meet Nasdaq Rule
Vivos Therapeutics shares surged 36% after a $4.5 million debt-to-equity swap with Streeterville Capital to address Nasdaq compliance, though the deal depends on new equity financing.
Wesfarmers Shares Slide Despite Profit Beat as Consumer Spending Concerns Mount
Wesfarmers shares tumbled over 5% despite reporting a half-year profit beat, as management flagged patchy consumer spending and upcoming price investments, overshadowing solid financial results.